Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipids Metabolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03771898
What this trial is testing

Intrathecal SHP611 in Children With Metachromatic Leukodystrophy

Who this might be right for
Metachromatic Leukodystrophy (MLD)
Shire 36
Post-approval studies (Phase 4)Study completedNCT00860964
What this trial is testing

Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women

Who this might be right for
Osteoporosis
Peking Union Medical College 221
Large-scale testing (Phase 3)Study completedNCT00794664
What this trial is testing

Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis

Who this might be right for
HypercholesterolemiaCoronary Heart Disease
Kastle Therapeutics, LLC 58
Not applicableStudy completedNCT07123844
What this trial is testing

Pumpkin Seeds or Oil Lower Serum Triglyceride Levels in Individuals With Hyperlipidaemia

Who this might be right for
HyperlipidemiaOverweight
Kastamonu University 159
Testing effectiveness (Phase 2)Looking for participantsNCT05791864
What this trial is testing

A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With TTX-381 for the Ocular Manifestations Associated With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease

Who this might be right for
Neuronal Ceroid Lipofuscinosis Type 2
Tern Therapeutics, LLC 16
Early research (Phase 1)Active Not RecruitingNCT06783881
What this trial is testing

Single-ascending Dose Study of Kylo-12 in Healthy Subjects

Who this might be right for
Hypertriglyceridemia
Kylonova (Xiamen) Biopharma co., LTD. 50
Not applicableStudy completedNCT01138371
What this trial is testing

Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers

Who this might be right for
Familial Hypercholesterolemia
Emory University 8
Not applicableStudy completedNCT01767077
What this trial is testing

Role of Milk Fat Globule Membranes in Dairy Foods: Health Effects in Humans

Who this might be right for
Hypercholesterolemia
Uppsala University 52
Not applicableLooking for participantsNCT06335771
What this trial is testing

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

Who this might be right for
ObesityNonalcoholic Fatty LiverDiabetes Type 2+1 more
Bettina Mittendorfer 60
Post-approval studies (Phase 4)Study completedNCT00145574
What this trial is testing

Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol

Who this might be right for
Hypercholesterolemia
Daiichi Sankyo 194
Testing effectiveness (Phase 2)Study completedNCT00903617
What this trial is testing

Study to Test GSK256073 in Patients With Dyslipidemia

Who this might be right for
DyslipidaemiasDyslipidemias
GlaxoSmithKline 80
Not applicableStudy completedNCT01138774
What this trial is testing

Effects of Lipoic Acid and Eicosapentaenoic Acid (EPA) in Human Obesity

Who this might be right for
ObesityBody FatInsulin Resistance
Clinica Universidad de Navarra, Universidad de Navarra 103
Testing effectiveness (Phase 2)Study completedNCT01576484
What this trial is testing

Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)

Who this might be right for
HypercholesterolemiaHeterozygous Familial Hypercholesterolemia
Regeneron Pharmaceuticals 58
Post-approval studies (Phase 4)Looking for participantsNCT07581808
What this trial is testing

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Disease (ASCVD)
University Medical Centre Ljubljana 60
Early research (Phase 1)Study completedNCT00944645
What this trial is testing

MK0524A Bioequivalence Study (0524A-059)

Who this might be right for
Dyslipidemia
Merck Sharp & Dohme LLC 188
Not applicableUnknownNCT06191328
What this trial is testing

A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes
Yufan Wang 40
Not applicableWithdrawnNCT01265836
What this trial is testing

Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes

Who this might be right for
Dyslipidemia
AstraZeneca 1,064
Not applicableStudy completedNCT00726908
What this trial is testing

Intramuscular Lipid and Insulin Action:Ethnic Aspects

Who this might be right for
Obesity
University of Alabama at Birmingham 69
Not applicableStudy completedNCT01478789
What this trial is testing

Efficacy of Plant Sterol-Fortified Dairy Product on Plasma Lipid and Plant Sterol Concentrations in Humans

Who this might be right for
Hypercholesterolemia
University of Manitoba 47
Large-scale testing (Phase 3)Ended earlyNCT03433755
What this trial is testing

Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 259
Next Page